Prediction Case File
YouTubeEvaluation Complete

Oracle Stock Prediction and Forecast [ORCL]

1 extracted signal · 1 resolved · 0 still active

StockInvest.us profile imageStockInvest.us20 Dec 2025, 04:23 UTC
Video preview for Oracle Stock Prediction and Forecast [ORCL]
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
0
Canonical correct result
Failed
1
Canonical failed result
Resolved success
0%
Open and excluded signals omitted
Source overview

AI-generated source summary

Oracle (ORCL) stock exhibits a mixed technical picture with short-term buy signals from indicators like MACD and Bollinger Bands, but a bearish outlook from longer-term moving averages and overall sentiment. Recent insider selling and a neutral analyst rating further contribute to caution. Despite a recent surge, the stock faces resistance at $215.57, with support at $187.50. A break below this support could signal further downside. The stock's current price appears overvalued based on the P/E ratio of 35.49.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

StockInvest.us

Tracked signals
1521
Historical success
43.3%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.